| Drug Name | STRENSIQ(Asfotase alfa) |
|---|---|
| Drug Class | |
| Risk minimization type |
patient guide
|
| Specialty (Theraputic area) |
Endocrine
|
| Risk |
instractions to patients, parents and caregivers of infant patients with paediatric-onset hypophosphatasia who would benefit from long-term enzyme replacement therapy |
| patient guide |
|